Moreover, miR-26a overexpression caused an increase of the p53/p21 pathway in in vitro and in vivo experiments, suggesting that miR-26a inhibits tumor growth via complex direct and indirect regulatory networks, influencing gender-specific HCC onset in at-risk populations. This evidence concerns the gene TP53 and neoplasm.